Cocaine influences beta-endorphin levels and release.

Area of Science:

• Neuroendocrinology
• Pharmacology
• Opioid System Research

Background:

• The endogenous opioid system, particularly beta-endorphin, plays a role in stress and reward pathways.
• Cocaine addiction is associated with alterations in neurochemical systems, including the opioid system.

Purpose of the Study:

• To investigate the effects of chronic cocaine administration on immunoreactive beta-endorphin (IR-BE) levels and release in male rats.
• To determine if cocaine impacts IR-BE concentrations in the plasma, pituitary, and hypothalamus.

Main Methods:

• Male rats were treated daily for ten days with varying doses of cocaine (2.5-20 mg/kg).
• IR-BE concentrations were measured in plasma, anterior pituitary (AP), neurointermediate lobe (NIL), and hypothalamus.
• In vitro release of IR-BE from AP and NIL was assessed.
• Chromatographic analysis was used to examine beta-endorphin and beta-lipotropin ratios.

Main Results:

• Cocaine consistently elevated IR-BE in plasma, AP, and NIL.
• In vitro release of IR-BE from AP and NIL was increased by cocaine treatment.
• Hypothalamic IR-BE concentrations remained unaffected by chronic cocaine.
• Chromatography indicated a slight decrease in the beta-endorphin to beta-lipotropin ratio in the AP.

Conclusions:

• Chronic cocaine administration stimulates the endogenous opiate system in rats.
• Cocaine elevates pituitary IR-BE levels and promotes beta-endorphin release.
• The pituitary, rather than the hypothalamus, is a primary site affected by cocaine's influence on beta-endorphin.